Is PCTL deceiving shareholders with false information on HOCI sales:

In the economic and political arenas, deception may appear in a wide variety of forms. Indeed, cynical observers might argue that a synonym for economic disinformation is “advertising.” In any case, examining the use of deception in marketing helps illustrate the difference between “fabrication and manipulation.” If false information is created and presented as true, this is fabrication. It is fabricated for the purpose of disinformation and is simply not true. Manipulation, on the other hand, is the use of information which is technically true, but is being presented out of context in order to create a false implication. This deception may be achieved by leaving out information or by associating valid information in such a way as to create false correlations. In the advertising world, companies usually avoid making false claims based on “fabricated” information. The laws against false advertising make such behavior problematical. Presenting “true” information “manipulated” to create a false impression, however, is difficult to prosecute. An example of some automobile manufacturers advertised cars with inefficient fuel consumption by noting how the range of their vehicles compared to smaller, more fuel efficient automobiles. They simply neglected to point out that their gas tanks were considerably larger than those in the smaller vehicles.

Well I don’t believe so because of independent reports of unprecedented sales:

In 2018, Pure & Clean’s annual revenue was $350,000. Amid the COVID-19 pandemic, you say sales of your natural disinfectants have surged in the last month. What were March sales?
It was equal to [total] 2019 sales, which were more than double 2018 sales. It’s kind of an interesting feeling in this time of so many people hurting with small businesses and even large businesses. We’re a great solution for what’s going on, for protecting yourself and then also for disinfecting surfaces and areas. Scaling to that is obviously something that you can’t prepare for and we obviously weren’t ready for."

I believe the reference is clearly to the annual revenue of $350,000 because it intentionally included the word total.

The article references natural disinfectants (HOCI being one).

The article talks about scaling.

The article talks about local demand and mentions working with some of the largest hospitals in the country.
It’s from individuals just wanting to get something to protect themselves. A lot of those individuals are people who are working on the front lines of the health care systems in town. A lot of people are in long-term care facilities that are taking care of a high-risk population. Honestly, our business right now, a lot of it is from all over the nation. Large companies reaching out that need to protect their employees. We work with some of the largest hospital systems in the nation.

The article talks about inability to meet demands.

We were supposed to be at the NCAA wrestling championships in March in Minnesota. I was supposed to go from there to Vision Expo East in New York and that was canceled. We were supposed to be at the Olympics this summer with our products. Team USA had already purchased product to be shipped out to Japan for the Olympics. Our sports line has pretty much been shut down, and our medical and consumer side is just crazy. We have to take care of our existing customers, and their medical side that are front line and we’re also working with some new ones, but we definitely can’t meet all the demand. The largest companies out there can’t come close to meeting all their demands. So, obviously a young, family-owned business like ours, we’re doing the best we can.

This article is all about HOCI and $700,000 Pure&Clean sold in March.

Their biggest HOCI item on their website is a 265 gallon tote.

It wouldn’t take too many of those to get to $700,000.


A Clearwater company saw sales for its advanced hypochlorous skin spray skyrocket from 120 bottles a month to 20,000 in March, and it appears COVID-19 may be the reason.
"I started polling my customers to find out, 'Why are you buying it? Why are you buying it?' Because I suspected it was something to do with the virus, but I can't make any claims," said Curativa Bay CEO Bill Maher.

Maher said the feedback he got was that people were attracted by the spray's main ingredient, hypochlorous acid.

Hypochlorous acid is named as the active ingredient in a number of disinfectants on the U.S. Environmental Protection Agency's "List N", which meet criteria for use against the coronavirus.

Gary did not fail!!!

In any start-up business there will be failures. You either quit or you press on.

PCTL’s financial situation was dire and they did what they had to do, toxic financing.

Does that constitute failure? No

Actually years and years before the Pandemic the company's share structure was small and its stock price was as high as $2.50.

If anything he got lucky.


Bringing PCTL’s flagship product, The Annihililyzer, to the market was not easy nor cheap.

“It is just a long arduous problem getting into the hospitals because of the layers of people that you have to go through,” said Grieco. “We have found that from the initial discussion with a hospital, it takes about six months before we get a system in there,” he explained. Grieco then shared that the Company has installed multiple systems in New York hospitals and are in discussions with additional New York facilities.

PCTL's plan was to increase market share in the healthcare and other industries.

How many hospitals are in NYC?

There are 62 acute care hospitals in New York City.

How many hospitals in NYC have at least one Annihilyzer System?

PCTL has installed at least 12 systems and gained 19% market share in NYC hospitals in less than 18 months.

That is success not failure!!!!!!!!!!!!!!!!

From the April 21, 2020 Stock Day Podcast:

“We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.

SUCCESS SUCCESS SUCCESS

Delivering to whom. Not the UK because they were still evaluating the Annihilyzer.

They either have a contract or a crystal ball.

HUGH simply HUGH

Timely and accurate....

FACTS not fiction

Well said.

PCTL is a rising star.

Any emerging company will have bumps in the road and PCTL had many.

I tell like I see it.

PCTL was on very shaky financial grounds and by the grace of HOCI that ground is not shaky any more. It is not solid yet however they are on the road to getting there.

FACTS no fiction

I just notice something I haven't really paid attention to before from the April 21, 2020 Stock Day Podcast:

he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.

I was so focused on the 25 systems, I didn't pay attention to the delivering.

Delivering to whom. Not UK because they were still evaluating the Annihilyzer.

They either have a contract or a crystal ball.

HUGH simply HUGH

Timely and accurate....

People are invested in PCTL because it is an emerging company with HUGH potential.


How could a company go from needing an “angel funder” with 3.5-5 million dollars to invest to record sales for the quarter and profitable for the month of March 2020 all in a week’s time?


I’ll tell you how HOCI!!!!

The question now is do they still need the 3.5-5 million dollars?

Do they have that 3.5-5 million dollars lined up due to their sudden windfall?

Don’t know

Thoughts

It has a record breaking Q1 for sales and revenues.

PCTL is a growing company and although it went through some toxic financing, they were fortunate enough to increase sales due to an unprecedented demand for HOCI that put them in a position to cover their burn rate. Also 2019 is the year where PCTL had the most system installs that will most likely increase exponentially in 2020.


PCTL revenues increased year to year with the biggest bump up in 2019. Please note the revenues for 2019 are just through the 3rd quarter as the 2019 10K has not been filed yet.

2015 $141
2016 $113,387
2017 123,105
2018 $266,122
2019 $534,852 thru 9 months
2020 $$$$$$$$$$$$$$
2021 $$$$$$$$$$$$$$$$$$$$$$
2022 $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

From the March 9, 2020 CEOCFO Magazine interview:

CEOCFO: Are you funded now? Are you seeking partnership, investments or funding as you move forward?

Mr. Grieco: Yes. Obviously, for a small company, that has been our greatest, most stubborn obstacle! First of all, the length of time that it takes to get into hospitals, and second of all, the length of time; even once you make your first presentation, the average time is about six months before you get them to agree to a Phase I Installation! Those things are very costly for us to provide. We are sending in our own Infection Preventionist, former Hospital EVS Administrator and our Technical Engineer to discuss our system, the fluid side itself and on how all the machines operate; that’s expensive. Therefore, yes! We are certainly looking for funding now; I guess the correct term would be an angel funder, from this point. Someone who understands what we do, sees its impact on the healthcare system of this country, sees its impact on a company that can deliver a solution to that and is willing to commit three and one half to five million dollars to that process.

From the PR dated March 13, 2020:

As a result of increased demand, an existing customer, BioBlasting LLC of Egg Harbor Township, New Jersey (www.bioblasting.com) has also purchased two of PCT Corp.’s largevolume Hydrolyte® generators.

"Our company has been growing exponentially over the past 2 years as our clients have discovered the benefits of our fluid solutions, which offer a high level of safety for both staff members and the general public," says BioBlasting CEO, Arthur Handson. "In light of the recent outbreak, our team has been working around the clock to ensure our products are accessible to all people and industries, particularly schools. Our goal is to minimize the effects of infectious disease outbreak by implementing proper preventive measures as well as assisting with eradication procedures as needed."

"We’ve had a great relationship with BioBlasting for over two years," says PCT LTD CEO, Gary Grieco. "As an existing sub-registrant, they have seen firsthand the safety and efficacy of our product. We’re happy to take this next step with them and excited to support them in their growth and efforts to serve their customers and communities."

As a result of heightened demand, PCT Corp. is expediting plans to increase its distribution networks. "With everything going on in the world today, our demand has increased by leaps and bounds" says PCT Corp. President, Bill Prince. "Adding key distributors to our network will allow us to strengthen sales channels and accelerate revenue growth while at the same time providing a much-needed product and service during these critical times. We will strategically add additional distributors and "partners," both In the United States and abroad. This will allow us to keep up with the strong need for our products."


From the March 16, 2020 Stock Day Podcast:

“How do you view the short to medium term of your company’s sales going forward?”, asked Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.

“I am more optimistic than I’ve ever been with this company, and I’ve been involved with this kind of technology since 1996,” closed Grieco.

Opportunity fell on their doorstep and they took full advantage of it.

PCTL is a stock with the right product at the right time.


PCTL to the Moon and Beyond!!!

BOOYAH

Dilution

From the 10Q dated April 13, 2020:

From October 1, 2019 through March 25, 2020, the Company issued a total of 265,453,351 shares of common stock upon the conversion of $286,043 of principal, $20,306 of interest and of fees pursuant to the convertible notes payable described in Note 6.

The question is did these shares start hitting the market after they were received?

There has been a lot of trading of PCTL stock since the conversions took place.

I don’t know if the owners of the conversion stock would want to hold onto a stock of a company that was so financially unstable.

PCTL still have debt to clean up no doubt.

Things are looking a lot rosier than they were a earlier this year.

We need to see a few quarters of financials to see where PCTL is headed. The debt wasn't created overnight and it is not going to be cleaned up overnight.

PCTL did major diluting to clean up some toxic financing. Prior to that they have sold shares to raise capital. Financially speaking, before this recent windfall PCTL was a respirator. They fell into a very fortunate position that presented itself before them just because of a product they happen to produce and sell.

PCTL would not have advance so quickly to have cash flow to cover their burn-rate, be on an accelerated pace towards profitability and
be prepared for double-digit growth into Q2 and beyond had it not been an increased attention of the ongoing coronavirus pandemic.

That being said the real gem in PCTL is their "Flagship" product the Annihilyzer. When they boost sales of that baby then things are really going to get hot. It is one the best if not the best Infection Control Systems on the market and it is definitely the most versatile and cost effective one.

FACTS not fiction

The following is an estimate of possible PCTL's production:

March 2020 Record Breaking

April 2020 Millions

May 2020 Many more Millions

Liquid production March 15th -June 30th. ……. Sound correct?

max (3 shifts 7 days /wk)
106 shifts@ 14000gals/shift=1,484,000gal @ $8.00/gal=$11,872,000
Cost labor average 20.00/hrx 2544hrs=$50,880

min (1 shift 5days /wk)
78 shifts@14000gals/shift=1,092,000gal @ $8.00/gal=$8,736,000
Cost labor average 20.00/hr x 624 hrs=12,480

360x3=1080 shifts/yr x 14,000 gal/shift=15,120,000 x $8.00/gal= $120,960,000 / yr
Income on liquid only.


Are we wo Unit production 25/mo in S.C. 25/mo in Ft Wayne=50/mo starting July through Dec=300 units @ 8,000 / mo lease for 6 mos=$ 14,400,000

Est 14 units in NYC
2 units in UK
5 units some where= 21 units @ $8,000/unit=168,000/mo x 12mo=$2,016,000


$2,016,000+$14,400,000=$16,416,000


FACTS not fiction

PCTL revenues for Q1 will be record breaking. I'll go out on the limb with our CEO and agree with him:

“I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.


From the PR dated March 18, 2020:

PCTL announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow.

From the PR dated March 25, 2020:

Following up on an earlier release from March 18th; a second 10,000-gallon fluid order has been shipped to an existing customer in the Midwest. Recurring orders to this sub-registrant are expected to follow in the coming weeks.

PTCL is continuing to expand business operations at a rapid rate while experiencing a dramatic increase in inquiries and orders from new and existing clients.

FACTS not fiction

Liquid production March 15th -June 30th. ……. Sound correct?

max (3 shifts 7 days /wk)
106 shifts@ 14000gals/shift=1,484,000gal @ $8.00/gal=11,872,000
Cost labor average 20.00/hrx 2544hrs=$50,880

min (1 shift 5days /wk)
78 shifts@14000gals/shift=1,092,000gal @ $8.00/gal=8,736,000
Cost labor average 20.00/hr x 624 hrs=12,480

360x3=1080 shifts/yr x 14,000 gal/shift=15,120,000 x $8.00/gal= $120,960,000 / yr
Income on liquid only.
Are we wo Unit production 25/mo in S.C. 25/mo in Ft Wayne=50/mo starting July through Dec=300 units @ 8,000 / mo lease for 6 mos=$ 14,400,000

Est 14 units in NYC
2 units in UK
5 units some where= 21 units @ $8,000/unit=168,000/mo x 12mo=2,016,000


2,016,000+14,400,000=16,416,000

Nobody knows for sure how many fluids PCTL sold.
What we do know from what PTCL press releases said such as:

Following up on an earlier release from March 18th; a second 10,000-gallon fluid order has been shipped to an existing customer in the Midwest. Recurring orders to this sub-registrant are expected to follow in the coming weeks.

and

“The demand for our products has been nothing short of explosive,” explains CEO Gary Grieco. “Due to this high demand, we are shifting our focus, in the short term, towards fluid production, sales, and distribution.”

and

“Growth has been tremendous,” says CFO Marion Sofield, adding that the company is expecting to report record sales and revenues in Q1 2020.


So it appears that when they got a couple of 10,000 gallon orders with more to follow and a dramatic increase in inquiries and orders from new and existing clients as the saying goes "the shit hit the fan"


Now information being reported all of the internet about the demand for HOCI just adds to the mystery to just how much fluid has PCTL been selling. The evidence says a lot. People are going to shocked at the numbers once they are released. Some are being conservative which is understandable.

PTCL to "Shock the World"!!!


FACTS not fiction

PCTL is doing quite well on their own and much better than any of their distributors as they are just adding to our coffers.

Liquid production March 15th -June 30th. ……. Sound correct?

max (3 shifts 7 days /wk)
106 shifts@ 14000gals/shift=1,484,000gal @ $8.00/gal=$11,872,000
Cost labor average 20.00/hrx 2544hrs=$50,880

min (1 shift 5days /wk)
78 shifts@14000gals/shift=1,092,000gal @ $8.00/gal=$8,736,000
Cost labor average 20.00/hr x 624 hrs=12,480

360x3=1080 shifts/yr x 14,000 gal/shift=15,120,000 x $8.00/gal= $120,960,000 / yr
Income on liquid only.


Are we wo Unit production 25/mo in S.C. 25/mo in Ft Wayne=50/mo starting July through Dec=300 units @ 8,000 / mo lease for 6 mos=$ 14,400,000

Est 14 units in NYC
2 units in UK
5 units some where= 21 units @ $8,000/unit=168,000/mo x 12mo=$2,016,000


$2,016,000+$14,400,000=$16,416,000

If one of PTCL's distributors sold $700,000 of HOCI in March 2020 then I believe and evidence clearly shows that PCTL sold more.

FACTS not fiction

In 2018, Pure & Clean’s annual revenue was $350,000. Amid the COVID-19 pandemic, you say sales of your natural disinfectants have surged in the last month. What were March sales?
It was equal to [total] 2019 sales, which were more than double 2018 sales. It’s kind of an interesting feeling in this time of so many people hurting with small businesses and even large businesses. We’re a great solution for what’s going on, for protecting yourself and then also for disinfecting surfaces and areas. Scaling to that is obviously something that you can’t prepare for and we obviously weren’t ready for."



The article talks about scaling.

The article talks about local demand and mentions working with some of the largest hospitals in the country.
It’s from individuals just wanting to get something to protect themselves. A lot of those individuals are people who are working on the front lines of the health care systems in town. A lot of people are in long-term care facilities that are taking care of a high-risk population. Honestly, our business right now, a lot of it is from all over the nation. Large companies reaching out that need to protect their employees. We work with some of the largest hospital systems in the nation.

The article talks about inability to meet demands.

We were supposed to be at the NCAA wrestling championships in March in Minnesota. I was supposed to go from there to Vision Expo East in New York and that was canceled. We were supposed to be at the Olympics this summer with our products. Team USA had already purchased product to be shipped out to Japan for the Olympics. Our sports line has pretty much been shut down, and our medical and consumer side is just crazy.We have to take care of our existing customers, and their medical side that are front line and we’re also working with some new ones, but we definitely can’t meet all the demand. The largest companies out there can’t come close to meeting all their demands. So, obviously a young, family-owned business like ours, we’re doing the best we can.

This article is all about HOCI and $700,000 Pure&Clean sold in March.

Their biggest HOCI item on their website is a 265 gallon tote.

It wouldn’t take too many of those to get to $700,000.

PCTL has been a lifeline in the midst of the Covid-19 Pandemic.


FACTS not fiction

Their flagship product Annihilyzer System is used in many hospitals in New York City. The system makes on-site and on-demand a Hypochlorous Acid (HOCI) that EPA approved for Emerging Pathogens Labeling for use against SARS-CoV-2, the novel coronavirus that causes the disease COVID-19.

The company also had to expand its HOCI production capabilities due to a dramatic increase in inquiries and orders from new and existing clients.

PCTL is able to produce up 10,000 gallons per day at its Little River facility. If they produced max amount daily that would equate to approximately $80,000 in revenues. Werks Manufacturing a fluid depot for PCTL is capable of producing 4,000 gallons a day that would equate to approximately $32,000 in revenues. Werks can expand prodution if needed.

Somebody else posted this.

Maybe if they see it they can give you more insight:

Liquid production March 15th -June 30th. ……. Sound correct?


max (3 shifts 7 days /wk)
106 shifts@ 14000gals/shift=1,484,000gal @ $8.00/gal=$11,872,000
Cost labor average 20.00/hrx 2544hrs=$50,880

min (1 shift 5days /wk)
78 shifts@14000gals/shift=1,092,000gal @ $8.00/gal=$8,736,000
Cost labor average 20.00/hr x 624 hrs=12,480

360x3=1080 shifts/yr x 14,000 gal/shift=15,120,000 x $8.00/gal= $120,960,000 / yr
Income on liquid only.

Are we wo Unit production 25/mo in S.C. 25/mo in Ft Wayne=50/mo starting July through Dec=300 units @ 8,000 / mo lease for 6 mos=$ 14,400,000

Est 14 units in NYC
2 units in UK
5 units some where= 21 units @ $8,000/unit=168,000/mo x 12mo=$2,016,000


$2,016,000+$14,400,000=$16,416,000

Why is PCTL stock set to make a major move?

First of all we need to understand the current trading area is based on the market makers just doing their job of creating a market.

PCTL sales have been record breaking sales and revenues for Q1 and expected to have double digit growth in Q2 and beyond. That alone should be favorable to the stock price movement.

What could launch stock price movement on a crazy run is knowledge.

The PCTL story is unknown to the trading public and the general public and for good reasons. It is a “stink pinky”. A lot of people won’t touch an OTC stock. It just went through some serious toxic financing. We had some very good local news stories about a small company from Little River, SC., however we need national news on the impact of HOCI during the Pandemic.

What major companies make and sell HOCI?


BASF SE. (Germany) OTCMKTS $48.80
Arkema S.A. (France) OTCMKTS $82.05
Lonza. (Swiss) OTCMKTS $480.00
Olin Corporation. NYSE $11.32
Nouryon (Private)
Occidental Petroleum Corporation. NYSE $14.67
Kuehne Company (Private)
AGC Chemicals (Private)
Surpass Chemical Company, Inc. Private
Westlake Chemical Corporation NYSE $42.02
When the story gets out about the impact of and the demand for Hypochlorous Acid during the pandemic and if Paradigm Convergence Technologies Corporation catches some press in the process then the possibility of an epic run may occur.
Why?

When people start to research HOCI and find out who the major players are they may want a piece of the action. Now some of the players listed are private so no action there. Many of the other ones although they make HOCI it is not necessary for disinfection in hospitals or similar businesses. Some will deliver 2500 gallons from a tank truck. Some are big into providing services to farms, diary, pool supplies distributors and water treatment plants.
If by happenstance some of these interested parties stubble across PCTL and take a close look they may take a dip and join the party.
PCTL went from the ashes of toxic financing to a company on a cash flow basis to cover the burn-rate in a six month period.

Due to increased attention as a result of the ongoing coronavirus pandemic, PCTL has been on an accelerated pace towards profitability and is preparing for double-digit growth into Q2 and beyond.

“Growth has been tremendous,” says CFO Marion Sofield, adding that the company is expecting to report record sales and revenues in Q1 2020.

“We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.

The fact that HOCI is selling like hotcakes and demand has been outstripping supply should be national news.

Nobody knows how much revenue PCTL generated with unprecedented demand for HOCI. However looking at some estimated possibilities and story of one of PCTL's distributors selling $700,000 of HOCI in the month of March alone is just mind-boggling:

Liquid production March 15th -June 30th. ……. Sound correct?

max (3 shifts 7 days /wk)
106 shifts@ 14000gals/shift=1,484,000gal @ $8.00/gal=$11,872,000
Cost labor average 20.00/hrx 2544hrs=$50,880

min (1 shift 5days /wk)
78 shifts@14000gals/shift=1,092,000gal @ $8.00/gal=$8,736,000
Cost labor average 20.00/hr x 624 hrs=12,480

360x3=1080 shifts/yr x 14,000 gal/shift=15,120,000 x $8.00/gal= $120,960,000 / yr
Income on liquid only.
Are we wo Unit production 25/mo in S.C. 25/mo in Ft Wayne=50/mo starting July through Dec=300 units @ 8,000 / mo lease for 6 mos=$ 14,400,000

Est 14 units in NYC
2 units in UK
5 units some where= 21 units @ $8,000/unit=168,000/mo x 12mo=2,016,000


2,016,000+14,400,000=16,416,000

People are invested in PCTL because it is an emerging company with HUGH potential.

It has a record breaking Q1 for sales and revenues.

PCTL is a growing company and although it went through some toxic financing, they were fortunate enough to increase sales due to an unprecedented demand for HOCI that put them in a position to cover their burn rate.


PCTL revenues increased year to year with the biggest bump up in 2019. Please note the revenues for 2019 are just through the 3rd quarter as the 2019 10K has not been filed yet.

2015 $141
2016 $113,387
2017 123,105
2018 $266,122
2019 $534,852 thru 9 months
2020 $$$$$$$$$$$$$$
2021 $$$$$$$$$$$$$$$$$$$$$$
2022 $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$


PCTL 10K will be filed on time.

The only chance of that happening is if the world stops.

The management of PCTL have work to hard for to long to start to drop the ball now.

Opportunity fell on the door step and they took full advantage of it.

PCTL is not a pump and dump.

Record sales and revenues aren't part of a pump and dump scheme.

There are plenty of shares out there until we get the 2nd and 3rd quarter reports in there will be a lot of up and down movement of the stock.

PCTL to the Moon and Beyond!!!

BOOYAH

PCTL revenues increased every year since 2016 and reach record revenues in 2020 and beyond.

The stock activity does not have the current fundamentals factored in and until they are, up and down and all around the stock price will go.

RESULTS will drive the stock price.

Nothing anyone posts here or any message board will ultimate determine the stock price. RESULTS simply RESULTS

FACTS not fiction

PCTL emerging from toxic financing to profitabilty.

The story of PCTL is about a little company trying to develop and introduce state of the art technology across different industries including healthcare, oil and gas, food services and agriculture. To truly see the evolution of PCTL one should follow the numbers and the place to start is the FINANCIALS. What does one see?

PCTL shares increased year to year with an enormous bump up in 2019 due to toxic financing. The company was selling shares to support operations.

PCTL revenues increased year to year with the biggest bump up in 2019. Please note the revenues for 2019 are just through the 3rd quarter as the 2019 10K has not been filed yet.

What does this all mean?

PCTL is a growing company and although it went through some toxic financing they were fortunate to increase sales due to an unprecedented demand for HOCI that put them in a position to cover their burn rate. Also 2019 is the year where PCTL had the most system installs that will most likely increase exponentially in 2020.

As far as the stock price goes once all the fundamentals of the PCTL hit the presses via financials in the upcoming quarters it will be reflected in the stock price.

The story of PCTL is changing daily. FACTS not fiction.

Below are some excerpts from recent filings, followed by some excerpts from press releases. People will try and oppose what is FACT with their fiction which is just not possible.

From the 2016 10K dated 4/14/2017

The number of shares outstanding of the registrant’s common stock as of April 14, 2017 was 37,542,572.

Revenues increased to $113,387 for the year ended December 31, 2016 compared to $141 for the year ended December 31, 2015. The revenue increases for 2016 were due to the increased volume of fluids sold and the sale of a piece of fluid producing equipment.

Research and development expenses increased to $147,917 for the 2016 year compared to $29,871 for the 2015 year. Research and development expenses increased for 2016 due to field testing required for EPA certification.

From the 2017 10K dated 4/17/2018

We had 204 stockholders of record as of April 17, 2018 and 43,409,238 shares outstanding. We have not declared dividends on our common stock and do not anticipate paying dividends on our common stock in the foreseeable future.

Revenues increased to $123,105 for the year ended December 31, 2017 compared to $113,387 for the year ended December 31, 2016. The revenue increases for 2017 were due to the increased volume of fluids sold, the sale of a piece of fluid producing equipment, licensing revenue from EPA sub registration, and placing equipment under the Company’s 2-year Systems Service Agreement (“lease”) in December, 2017.

Research and development expenses increased to $315,385 for the 2017 year compared to $147,917 for the 2016 year. Research and development expenses increased for 2017 due to testing of the application of the Hydrolyte® technology in the oil and gas industry; as a biocide in institutional facilities, such as, hospitals, jails and medical facilities; and in agriculture and food processing.

From the 2018 10K dated 4/15/2019:

The number of shares of the Registrant’s common stock outstanding as of April 12, 2019 was 51,643,048.

Revenues increased to $266,122 for the year ended December 31, 2018 compared to $123,105 for the year ended December 31, 2017. The revenue increases for 2018 were due to the increased volume of fluids sold, the sale of a piece of fluid producing equipment, licensing revenue from EPA sub registration, and placing equipment under the Company’s 2-year Systems Service Agreements (“leases”).

From the 2019 3rd 10Q

The number of shares outstanding of the registrant’s common stock as of April 10, 2020 was 527,813,393 which does not include 427,186,607 shares of common stock reserved against default/conversion of convertible debt.

Revenues increased to $534,852 for the nine months ended September 30, 2019 compared to $153,337 for the nine months ended September 30, 2018. The revenue increase for the period was due to the increased volume of fluids sold, the sale of a duplicate US EPA Registration, licensing revenue from EPA sub registrations, equipment sales and the additional revenue from recurring leased-equipment income.


PCTL emerging from toxic financing to profitabilty.

Paradigm Convergence Technologies Corp (PCT) is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment and medical devices.

PCTL launched its flagship product, Annihilyzer® Infection Control System that is designed to help alleviate the growing problems of Hospital Acquired in May 2018.
https://www.para-con.com/images/docs/PCTL5-16-18.pdf

PCTL successfully installed the PCT Annihilyzer® Infection Control System at Johnston UNC Health Care Hospital, in Smithfield, North Carolina in May 2018.
https://www.para-con.com/images/docs/PCTL5-18-18.pdf

PCTL provided with sufficient independent laboratory AOAC efficacy testing data to support PCT claims that our Hydrolyte® product is effective in killing a broad range of microbial pathogens, including C-Diff, TB, HCV, HIV-1, CRE, VRE and MRSA, as well as other bacteria and viruses, qualifying Hydrolyte® as a hospital-level disinfectant in May 2018.
https://www.para-con.com/images/docs/PCTL5-22-18.pdf

PCTL is increasing production capacity in response to expected demand for its Annihilyzer® Infection Control Systems and Large Volume Systems in May 2018. Current sustainable single shift capacity of the facility is 20 to 25 units per month, which can be increased to 40 to 50 units per month with additional production personnel and shifts.
https://www.para-con.com/images/docs/PCTL5-29-18.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions for global sustainability announced today it has entered into a license and distribution agreement with a long established agricultural chemical company. The one-year exclusive agreement, subject to renewal, provides for license fees and monthly royalty and equipment leasing payments in September 2018.
https://www.para-con.com/images/docs/PCTL-9-26-18.pdf

PCTL announced today it has entered into a Master Services Agreement with a New Yorkbased hospital supply and services company for the installation of two Annihilyzer® Infection Control Systems to prevent hospital-acquired infections (HAI’s) in hospitals in its market area in October 2018.
https://www.para-con.com/images/docs/PCTL10-25-18.pdf

PCTL announced today that, with its New York-based representative, it has entered into a contractual agreement for the installation and operation of two Annihilyzer® Infection Control Systems in a major Brooklyn hospital in November 2018.
https://www.para-con.com/images/docs/PCTL11-01-18.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, secured a three-year Master Service Agreement and recently installed its Annihilyzer® Infection Control System at Carson Tahoe Regional Medical Center in Carson City, NV.
https://www.para-con.com/images/docs/PCTL-01-10-19.pdf

PCTL, a leader in environmentally safe, nontoxic, antimicrobial solutions for infection control, announced today it has entered into a Manufacturer’s Representative Agreement with DTS of Cleveland, OH (DTS), for the sale of Annihilyzer® Infection Control Systems in Ohio, West Virginia, Western Pennsylvania, Michigan, Indiana and Kentucky.
https://www.para-con.com/images/docs/PCTL-02.07.19.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has received a repeat order for two large volume Hydrolyte® Systems from one of its existing food processing customers. The referenced food processing customer’s plant currently has two systems at one facility and purchased another large volume system from PCT as a result of their 2018 plant expansion.
https://www.para-con.com/images/docs/PCTL-02.12.19.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has sold and is currently installing a large volume C-104 Hydrolyte® Systems to an existing customer, H2S Safe Treat, Inc. of Ada, OK (H2S).
https://www.para-con.com/images/docs/PCTL-02.25.19.pdf

PCTL, announced today that ACE Janitorial Supply Company (“ACE”), PCT Corp.’s distributor for the New York hospital and healthcare market, received a new purchase order for Morgan Stanley Presbyterian Children’s Hospital to continue using PCT Corp.’s patented Annihilyzer® Infection Control System following a successful 60-day trial within the facility.
https://www.para-con.com/images/docs/PCTL5-06-19.pdf

PCTL, announces another successful phase one installation of PCT Corp.’s Annihilyzer® Infection Control System in coordination with its primary healthcare distributor, ACE Janitorial Services. PCT Corp.installed the premier cabinet model of its Annihilyzer® Infection Control System this week at Mount Sinai South Nassau Medical Center located in Oceanside, NY.
https://www.para-con.com/images/docs/PCTL10-07-19.pdf

PCTL, a Little River, South Carolina company and the designer of the Annihilyzer® Infection Control System, a world class whole room cleaning and disinfecting system for hospitals and health care facilities, is pleased to announce that it has shipped the first overseas Annihilyzer® Infection Control System to its partner company, PCT Europe Ltd., in the United Kingdom.
https://www.para-con.com/images/docs/PCTL10-22-19.pdf

Most recently, PCTL Environmental Solutions, Inc. (“AES, Inc.”) of Meeker, Oklahoma. AES, Inc. purchased two (2) high-volume units of PCT Corp.’s equipment and is building out has executed a collaborative agreement with Advanced a 2,500 s.f. production facility as it develops its oil & gas and Cannabis applications December 2019.
https://www.para-con.com/images/docs/PCTL12-16-19.pdf

PCT LTD (OTC Pink: PCTL) ("PCTL"), as the result of its wholly owned operating company’s (PCT Corp.’s) growth, is pleased to announce a new distribution partner in Puerto Rico in addition to other ongoing expansion efforts.ABC Medical of San Juan, Puerto Rico (www.abcmedicalpr.com) has signed on to be a distributor and sub-registrant for PCT Corp. in Puerto Rico. Through a sub-registration licensing agreement, which includes royalty revenues to PCT Corp., ABC Medical will initially receive one large volume Hydrolyte® System for the purpose of producing, bottling, and distributing Hydrolyte® solution to their existing hospital and healthcare clients. The move signals the company’s first distribution agreement in an area outside the continental United States March 13, 2020.
https://www.para-con.com/images/docs/PCTL03-13-20.pdf

PCT LTD Discusses Their Unique Annihilyzer™ Disinfecting System and Impact of The Coronavirus with The Stock Day Podcast
Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added. “I am more optimistic than I’ve ever been with this company, and I’ve been involved with this kind of technology since 1996,”
https://www.para-con.com/images/docs/PCTL03-16-20.pdf

PCTLis pleased to announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow in March 2020
https://www.para-con.com/images/docs/PCTL03-18-20.pdf

Little River, South Carolina — (March 25, 2020) PCT LTD (OTC Pink: PCTL) ("PCTL") is continuing to expand business operations at a rapid rate while experiencing a dramatic increase in inquiries and orders from new and existing clients. Following up on an earlier release from March 18th; a second 10,000-gallon fluid order has been shipped to an existing customer in the Midwest. Recurring orders to this sub-registrant are expected to follow in the coming weeks.
https://www.para-con.com/images/docs/PCTL03-25-20.pdf

PCTL is pleased to announce that it has received approval for “emerging pathogens” labeling with the US EPA in March 2020. Hydrolyte® has demonstrated effectiveness against viruses similar to SARS-CoV-2 virus on hard, non-porous surfaces. Therefore, Hydrolyte® can be used against SARS-CoV-2 virus when used in accordance with the directions for use against Norovirus and Rhinovirus type 16 on hard, non-porous surfaces. Refer to the CDC website at https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cleaning-disinfection.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fcleaning-disinfection.html for additional information.
https://www.para-con.com/images/docs/PCTL03-27-20.pdf

PCTL is excited to announce they have increased production capacity at their Little River, South Carolina facility. Updating an earlier release (March 25th), the South Carolina facility is now capable of producing up to 10,000 gallons of fluids per day. A marked increase over earlier capabilities. The company is now better positioned to meet the growing demand for its Hypochlorous Acid-based disinfecting fluids.
https://www.para-con.com/images/docs/PCTL04-07-20.pdf

PCTL is pleased to announce new growth and expansion activities in the UK and NYC. PCT Europe Ltd, the UKbased partner of PCTL is pleased to announce they have signed an exclusive trading partnership/distributor agreement with an NHS (U.K. National Health Service) company in April 2020. In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf

PCT LTD Discusses Its Rapid Growth and Expansion Plans with The Stock Day Podcast in April 2020. The conversation then turned to dilution and outstanding shares. Grieco noted that dilution occurred prior to January 2020, but shared that any shares that are currently being issued are meant for growth. “We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf

PCTL is pleased to announce they are continuing their expansion efforts with additional hospital installations and have reached distributor agreements with three new entities in May 2020. Two of the new distributors will operate in the western United States (California and Utah primarily) while the third distributor is based in South Carolina, shoring up the company’sexisting presence in the state. The company is also announcing a new hospital installation. Following up on an earlier release from April 14th, installation in a large NYC area hospital is expected to commence early next week through PCT’s primary healthcare distributor ACE Janitorial Services. Two additional installations are scheduled in NYC hospitals over the following weeks.
https://www.para-con.com/images/docs/PCTL05-08-20.pdf

PCTL is pleased to announce two additional hospital installations scheduled within this month, announces the relationship between PCTL and Florida-based Sapphire Disinfection Solutions, as well as declares the addition of three new distributors in May 2020. PCTL’s newest distributors are setting up operations in Illinois, New Jersey, and in central South Carolina. Two of the newest distributors will also have supplemental product registrations and the third will be a re-sale distributor of PCTL’s Hydrolyte disinfectant into medical facilities, schools and to state and municipal governments.
https://www.otcmarkets.com/stock/PCTL/news/story?e&id=1608744



FACTS not fiction

People are invested in PCTL because it is an emerging company with HUGH potential.

It has record breaking Q1 for sales and revenues.

Yes PCTL had toxic financing to survive.

No more toxic financing with the way cash is flowing

Some posters here believe that the yearly won't be filed on time.

The only chance of that happening is if the world stops.

The management of PCTL have work to hard for to long to start to drop the ball now.

Opportunity fell on PCTL's door step and they took full advantage of it.

PCTL flagship product is one the best and the most versatile infection control system in the marketplace.

People talk about a pump and dump.

Record sales and revenues aren't part of a pump and dump scheme.

PCTL to the Moon and Beyond!!!

BOOYAH

Oh yea some posters talk about fluff PRs

Here are quite a few of them and can anyone point out the fluff to me because all I see is green:)


PCTL emerging from toxic financing to profitabilty.

Paradigm Convergence Technologies Corp (PCT) is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment and medical devices.

PCTL launched its flagship product, Annihilyzer® Infection Control System that is designed to help alleviate the growing problems of Hospital Acquired in May 2018.
https://www.para-con.com/images/docs/PCTL5-16-18.pdf

PCTL successfully installed the PCT Annihilyzer® Infection Control System at Johnston UNC Health Care Hospital, in Smithfield, North Carolina in May 2018.
https://www.para-con.com/images/docs/PCTL5-18-18.pdf

PCTL provided with sufficient independent laboratory AOAC efficacy testing data to support PCT claims that our Hydrolyte® product is effective in killing a broad range of microbial pathogens, including C-Diff, TB, HCV, HIV-1, CRE, VRE and MRSA, as well as other bacteria and viruses, qualifying Hydrolyte® as a hospital-level disinfectant in May 2018.
https://www.para-con.com/images/docs/PCTL5-22-18.pdf

PCTL is increasing production capacity in response to expected demand for its Annihilyzer® Infection Control Systems and Large Volume Systems in May 2018. Current sustainable single shift capacity of the facility is 20 to 25 units per month, which can be increased to 40 to 50 units per month with additional production personnel and shifts.
https://www.para-con.com/images/docs/PCTL5-29-18.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions for global sustainability announced today it has entered into a license and distribution agreement with a long established agricultural chemical company. The one-year exclusive agreement, subject to renewal, provides for license fees and monthly royalty and equipment leasing payments in September 2018.
https://www.para-con.com/images/docs/PCTL-9-26-18.pdf

PCTL announced today it has entered into a Master Services Agreement with a New Yorkbased hospital supply and services company for the installation of two Annihilyzer® Infection Control Systems to prevent hospital-acquired infections (HAI’s) in hospitals in its market area in October 2018.
https://www.para-con.com/images/docs/PCTL10-25-18.pdf

PCTL announced today that, with its New York-based representative, it has entered into a contractual agreement for the installation and operation of two Annihilyzer® Infection Control Systems in a major Brooklyn hospital in November 2018.
https://www.para-con.com/images/docs/PCTL11-01-18.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, secured a three-year Master Service Agreement and recently installed its Annihilyzer® Infection Control System at Carson Tahoe Regional Medical Center in Carson City, NV.
https://www.para-con.com/images/docs/PCTL-01-10-19.pdf

PCTL, a leader in environmentally safe, nontoxic, antimicrobial solutions for infection control, announced today it has entered into a Manufacturer’s Representative Agreement with DTS of Cleveland, OH (DTS), for the sale of Annihilyzer® Infection Control Systems in Ohio, West Virginia, Western Pennsylvania, Michigan, Indiana and Kentucky.
https://www.para-con.com/images/docs/PCTL-02.07.19.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has received a repeat order for two large volume Hydrolyte® Systems from one of its existing food processing customers. The referenced food processing customer’s plant currently has two systems at one facility and purchased another large volume system from PCT as a result of their 2018 plant expansion.
https://www.para-con.com/images/docs/PCTL-02.12.19.pdf

PCTL, a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has sold and is currently installing a large volume C-104 Hydrolyte® Systems to an existing customer, H2S Safe Treat, Inc. of Ada, OK (H2S).
https://www.para-con.com/images/docs/PCTL-02.25.19.pdf

PCTL, announced today that ACE Janitorial Supply Company (“ACE”), PCT Corp.’s distributor for the New York hospital and healthcare market, received a new purchase order for Morgan Stanley Presbyterian Children’s Hospital to continue using PCT Corp.’s patented Annihilyzer® Infection Control System following a successful 60-day trial within the facility.
https://www.para-con.com/images/docs/PCTL5-06-19.pdf

PCTL, announces another successful phase one installation of PCT Corp.’s Annihilyzer® Infection Control System in coordination with its primary healthcare distributor, ACE Janitorial Services. PCT Corp.installed the premier cabinet model of its Annihilyzer® Infection Control System this week at Mount Sinai South Nassau Medical Center located in Oceanside, NY.
https://www.para-con.com/images/docs/PCTL10-07-19.pdf

PCTL, a Little River, South Carolina company and the designer of the Annihilyzer® Infection Control System, a world class whole room cleaning and disinfecting system for hospitals and health care facilities, is pleased to announce that it has shipped the first overseas Annihilyzer® Infection Control System to its partner company, PCT Europe Ltd., in the United Kingdom.
https://www.para-con.com/images/docs/PCTL10-22-19.pdf

Most recently, PCTL Environmental Solutions, Inc. (“AES, Inc.”) of Meeker, Oklahoma. AES, Inc. purchased two (2) high-volume units of PCT Corp.’s equipment and is building out has executed a collaborative agreement with Advanced a 2,500 s.f. production facility as it develops its oil & gas and Cannabis applications December 2019.
https://www.para-con.com/images/docs/PCTL12-16-19.pdf

PCT LTD (OTC Pink: PCTL) ("PCTL"), as the result of its wholly owned operating company’s (PCT Corp.’s) growth, is pleased to announce a new distribution partner in Puerto Rico in addition to other ongoing expansion efforts.ABC Medical of San Juan, Puerto Rico (www.abcmedicalpr.com) has signed on to be a distributor and sub-registrant for PCT Corp. in Puerto Rico. Through a sub-registration licensing agreement, which includes royalty revenues to PCT Corp., ABC Medical will initially receive one large volume Hydrolyte® System for the purpose of producing, bottling, and distributing Hydrolyte® solution to their existing hospital and healthcare clients. The move signals the company’s first distribution agreement in an area outside the continental United States March 13, 2020.
https://www.para-con.com/images/docs/PCTL03-13-20.pdf

PCT LTD Discusses Their Unique Annihilyzer™ Disinfecting System and Impact of The Coronavirus with The Stock Day Podcast
Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added. “I am more optimistic than I’ve ever been with this company, and I’ve been involved with this kind of technology since 1996,” closed Grieco, adding that he hopes to update listeners again in
https://www.para-con.com/images/docs/PCTL03-16-20.pdf

PCTLis pleased to announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow in March 2020
https://www.para-con.com/images/docs/PCTL03-18-20.pdf

Little River, South Carolina — (March 25, 2020) PCT LTD (OTC Pink: PCTL) ("PCTL") is continuing to expand business operations at a rapid rate while experiencing a dramatic increase in inquiries and orders from new and existing clients. Following up on an earlier release from March 18th; a second 10,000-gallon fluid order has been shipped to an existing customer in the Midwest. Recurring orders to this sub-registrant are expected to follow in the coming weeks.
https://www.para-con.com/images/docs/PCTL03-25-20.pdf

PCTL is pleased to announce that it has received approval for “emerging pathogens” labeling with the US EPA in March 2020. Hydrolyte® has demonstrated effectiveness against viruses similar to SARS-CoV-2 virus on hard, non-porous surfaces. Therefore, Hydrolyte® can be used against SARS-CoV-2 virus when used in accordance with the directions for use against Norovirus and Rhinovirus type 16 on hard, non-porous surfaces. Refer to the CDC website at https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cleaning-disinfection.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fcleaning-disinfection.html for additional information.
https://www.para-con.com/images/docs/PCTL03-27-20.pdf

PCTL is excited to announce they have increased production capacity at their Little River, South Carolina facility. Updating an earlier release (March 25th), the South Carolina facility is now capable of producing up to 10,000 gallons of fluids per day. A marked increase over earlier capabilities. The company is now better positioned to meet the growing demand for its Hypochlorous Acid-based disinfecting fluids.
https://www.para-con.com/images/docs/PCTL04-07-20.pdf

PCTL is pleased to announce new growth and expansion activities in the UK and NYC. PCT Europe Ltd, the UKbased partner of PCTL is pleased to announce they have signed an exclusive trading partnership/distributor agreement with an NHS (U.K. National Health Service) company in April 2020. In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf

PCT LTD Discusses Its Rapid Growth and Expansion Plans with The Stock Day Podcast in April 2020. The conversation then turned to dilution and outstanding shares. Grieco noted that dilution occurred prior to January 2020, but shared that any shares that are currently being issued are meant for growth. “We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf

PCTL is pleased to announce they are continuing their expansion efforts with additional hospital installations and have reached distributor agreements with three new entities in May 2020. Two of the new distributors will operate in the western United States (California and Utah primarily) while the third distributor is based in South Carolina, shoring up the company’sexisting presence in the state. The company is also announcing a new hospital installation. Following up on an earlier release from April 14th, installation in a large NYC area hospital is expected to commence early next week through PCT’s primary healthcare distributor ACE Janitorial Services. Two additional installations are scheduled in NYC hospitals over the following weeks.
https://www.para-con.com/images/docs/PCTL05-08-20.pdf

PCTL is pleased to announce two additional hospital installations scheduled within this month, announces the relationship between PCTL and Florida-based Sapphire Disinfection Solutions, as well as declares the addition of three new distributors in May 2020. PCTL’s newest distributors are setting up operations in Illinois, New Jersey, and in central South Carolina. Two of the newest distributors will also have supplemental product registrations and the third will be a re-sale distributor of PCTL’s Hydrolyte disinfectant into medical facilities, schools and to state and municipal governments.
https://www.otcmarkets.com/stock/PCTL/news/story?e&id=1608744

People are invested in PCTL because it is an emerging company with HUGH potential.

It has a record breaking Q1 for sales and revenues.

Some posters here believe that the yearly won't be filed on time.

The only chance of that happening is if the world stops.

The management of PCTL have work to hard for to long to start to drop the ball now.

Opportunity fell on the door step and they took full advantage of it.

People talk about a pump and dump.

Record sales and revenues aren't part of a pump and dump scheme.

PCTL to the Moon and Beyond!!!

BOOYAH

Not according to the CEO:

“How do you view the short to medium term of your company’s sales going forward?”, asked Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.

There are very few companies that can provide a hospitals with an Infection Control Systems (ICS) that can provide real-time updates, produces two products –a chlorine-based antimicrobial agent and an excellent degreasing cleaner on-site, is people friendly, cost effective as to other ICSs and is Green Seal Certified end-to-end.

PCTL history is trying to build a state of the art Infection Control System and bring it to the market.

The went through toxic financing and all sorts of trials and tribulations to get their system into hospitals.

They have broken through and are growing.

There are plenty other companies that are well funded and with good market share however it is only a matter of time when decision-makers will to turn to a better and more cost effective alternative.

If a hospital is using say a UV ICS it can clean a room however it doesn't have the capability to produce a degreasing cleaner. That particular hospital would have to spend extra money to supply it.

PCTL have been in limited markets and the biggest market they are in NYC has shown hospital after hospital acquiring the system.


As far as hard evidence. of What?

PCTL is growing.

They are not going to blow-up overnight.

They did make a lot of money in a short period of time selling HOCI because it was in such high demand.

Heck one of their distributors made $700,000 in the month of March.

How much do you think PCTL made in the month of March?

Based on what the CEO said it was a lot of money.

“How do you view the short to medium term of your company’s sales going forward?”, asked Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.

Those are very good questions.

Nobody on this board can answer.

If you really want an answer called the company as they are the entity that put out the press release,

If you don't want an answer keep asking on this board.

FACTS not fiction

Clearwater Company Saw Demand for Hypochlorous Acid Product Spike as Coronavirus Spread

PUBLISHED 5:23 PM ET MAY. 19, 2020 UPDATED 7:19 AM ET MAY. 20, 2020

https://www.baynews9.com/fl/tampa/news/2020/05/19/clearwater-company-saw-demand-for-hypochlorous-acid-product-spike-as-coronavirus-spread

CLEARWATER, Fla. — A Clearwater company saw sales for its advanced hypochlorous skin spray skyrocket from 120 bottles a month to 20,000 in March, and it appears COVID-19 may be the reason.


"I started polling my customers to find out, 'Why are you buying it? Why are you buying it?' Because I suspected it was something to do with the virus, but I can't make any claims," said Curativa Bay CEO Bill Maher.

The company's website lists some of the benefits of the product as improving skin tone and providing relief to injuries, "with proven cleansing, soothing, and calming affects."

Maher said the feedback he got was that people were attracted by the spray's main ingredient, hypochlorous acid.

Hypochlorous acid is named as the active ingredient in a number of disinfectants on the U.S. Environmental Protection Agency's "List N", which meet criteria for use against the coronavirus.

"Hypochlorous acid is actually kind of the water form of things that we use to disinfect, like bleach," said Dr. Michael Teng, an associate professor in the University of South Florida's Department of Internal Medicine.

"There's no chemicals in it, there's no additives," said Maher of his company's skin spray. "It's a proprietary way to stabilize it so it stays in the bottle."
Maher said Curativa Bay has mailed shipments nationwide, including to hospitals and police stations. He said the company isn't making any claims about the skin spray's impact on coronavirus.

It's also in the process of making a cleaning product using hypochlorous acid, an area Teng said the substance is known to be beneficial in.

"If you spray it on there and let it sit for a few minutes — I think the recommended number of minutes is about ten — it's going to kill the virus, even viruses that are a little bit harder to kill than the coronavirus," said Teng.




FACTS not fiction

PCTL

You to funny.

I appreciate your enthusiasm as I'm sure many others do as well.

Certainly the company has much information to report and it all will come out in due time whether through PRs or SEC reports.

I believe we as investors are at a crossroads of knowing what we own however we all want what Rod Tidwell wanted in the movie Jerry McGuire:

FACTS not fiction

That is a likely scenario with one of our distributors selling $700,000 worth of HOCI in March.

PCTL focused their operations on fluid sales when the demand surged. Doing so they did not stop producing their flagship product,"the Annihilyzer" per March 25, 2020 press release:

Jody Read, COO stated: “We are still continuing to see significant interest in the facility-based Annihilyzer® Infection Control System. However, we are not able to coordinate installations due to travel restrictions and availability of hospital staff to implement the systems. We are continuing to build systems and at the same time utilize our current South Carolina facility’s capabilities with large volume systems to produce mass quantities of disinfectant for distributors and hospitals. PCT’s previous investment in building large volume systems and the testing facility was easily modified into a fluid production operation with little to no additional expense. In addition, we are continuing to engage suppliers to propagate the pipeline of systems in process.”

CEO Gary Grieco adds. “We’re temporarily adjusting our focus towards where we can have the biggest impact. With everything going on in the country right now, we have a tremendous opportunity to not only grow as a business, but to help our fellow Americans in their time of need.”

“How do you view the short to medium term of your company’s sales going forward?”, asked Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.


Due to increased attention as a result of the ongoing coronavirus pandemic, PCTL has been on an accelerated pace towards profitability and is preparing for double-digit growth into Q2 and beyond.


FACTS not fiction

Thanks Ken

If my memory isn't failing me, I believe we have an investor from this board visiting the Little River facility this week.

Can anyone confirm?

You want numbers, I'll give you numbers.

How about $700,000 worth of HOCI sold by one of PCTL distributors in the month of March.

How much HOCI do you think PCLT sold in the month of March.

There is a Joe Tippmann that plays OT for Wisconsin Badgers and is from none other than Fort Wayne, IN.

son, nephew or cousin or PCTL's new design engineer:)

It gets is even better from the April 7, 2020 PR:

Updating an earlier release (March 25th), the South Carolina facility is now capable of producing up to 10,000 gallons of fluids per day. A marked increase over earlier capabilities. The company is now better positioned to meet the growing demand for its Hypochlorous Acid-based disinfecting fluids.

The company has also been hiring additional support staff to support growing business operations. Most recently, the company engaged Joseph Tippmann, graduate of The University of Michigan’s Industrial Design and Architecture program, as a new design engineer. Tippmann joined the company on a contract basis initially and has spent the past two weeks performing design updates on Annihilyzer and Hydrolyte Rack systems in addition to helping design a more modular system for easier assembly.

Tippmann is also a co-owner of Werks Manufacturing, a Fort Wayne, Indiana based manufacturing company which PCTL engages for the purpose of manufacturing and assembling parts for use in the company’s Annihilyzer® Infection Control System and other systems.

Werks Manufacturing is expanding their operation and will increase parts and assembly production to meet PCTL’s growing demand. In addition, Werks will also serve as a fluid depot for PCTL’s clients in the northern Midwest part of the United States. Werks will initially be capable of producing up to 4,000 gallons per day of disinfecting fluids, including Hydrolyte®,for sale and use by PCTL to clients in Detroit, Chicago, and throughout the region. This fluid production capacity can be increased as needed to serve growing demand.

FACTS not fiction

PCTL focused their operations on fluid sales when the demand surged. Doing so they did not stop producing their flagship product,"the Annihilyzer" per March 25, 2020 press release:

Jody Read, COO stated: “We are still continuing to see significant interest in the facility-based Annihilyzer® Infection Control System. However, we are not able to coordinate installations due to travel restrictions and availability of hospital staff to implement the systems. We are continuing to build systems and at the same time utilize our current South Carolina facility’s capabilities with large volume systems to produce mass quantities of disinfectant for distributors and hospitals. PCT’s previous investment in building large volume systems and the testing facility was easily modified into a fluid production operation with little to no additional expense. In addition, we are continuing to engage suppliers to propagate the pipeline of systems in process.”

CEO Gary Grieco adds. “We’re temporarily adjusting our focus towards where we can have the biggest impact. With everything going on in the country right now, we have a tremendous opportunity to not only grow as a business, but to help our fellow Americans in their time of need.”

Due to increased attention as a result of the ongoing coronavirus pandemic, PCTL has been on an accelerated pace towards profitability and is preparing for double-digit growth into Q2 and beyond.


FACTS not fiction

Come on man there is a world wide demand for Infection Controls Systems that suppliers can't keep up with. PCTL or any other company can sell as many systems as they can make.

The need for Infection Control Systems because of the pandemic is record breaking.

271,000 Infection Controls Systems sold yearly!!!

Bids are being requested in the thousands!!!

Growth Rates Through The ROOF 400%...600%...2000%!!!

In Coronavirus Fight, Robots Report For Disinfection Duty

https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/

Large-scale coronavirus testing continues to lag and a vaccine could be at least one year away. But in the battle against world pandemic a rapidly expanding brigade of robots is answering an urgent call of duty: surface disinfection.


They're rolling in by the hundreds and not just into hospitals and nursing homes but across a wide spectrum of public spaces, including government buildings, offices, hotels, airports and universities. Administrators of all stripes, desperate to keep people safe, are looking to a global robotics industry that has been quick to respond.

Anybody willing to go out on a limb with PCTL's CEO?

“How do you view the short to medium term of your company’s sales going forward?”, asked Jolly. Grieco shared that the Company remains undervalued considering the effectiveness of their hypochlorous disinfectant system, which is now entering its ninth hospital. “I think that one of the big problems with any small company is profitability,” said Grieco, “I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter,” shared Grieco. “I think this month will set a stage,” he added.

“I am more optimistic than I’ve ever been with this company, and I’ve been involved with this kind of technology since 1996,” closed Grieco.

The up and down of PCTL stock price is currently being drive by the market makers doing their job. The stock price is where it should be.

Once the fundamentals factors based on a company's earnings and profitability from producing and selling goods and services is taken into account then the market will respond.

How has PCTL's fundamentals changed that is not reflected in the stock price?

Just how much cash is flowing.

What are the numbers that reflect record sales and revenues for Q1.

Update of PCT Europe.

How many more Hospital installations of the Annihilyzer System.

What is the estimated double-digit growth and profits expected into Q2 and beyond.


All will be answered sooner or later.

Did somebody say competition?


The demand for Infection Control Systems is at an all time HIGH!!!

Ride the wave

Roll Baby Roll

By the Numbers

271,000 Infection Controls Systems sold yearly!!!

Bids are being requested in the thousands!!!

Growth Rates Through The ROOF 400%...600%...2000%!!!

The need for Infection Control Systems because of the pandemic is record breaking.

Never in the course of human history has so many wanted so much that companies just can’t keep up.

The pandemic has caused an epidemic in not only health care but everywhere.

These systems are needed and wanted all over the world.

Xenen a private company Sees Surge In Orders As COVID-19 Pandemic Escalates

Xenex is being asked for bids on quantities of robots “in the thousands,”

The recent increase in business follows a year in which Xenex turned the corner to profitability, according to Miller. Revenue percentage growth was up about 20 percent in 2019, but Miller projects growth will be anywhere from 400 to 600 percent in 2020.

I wonder what PCTL growth will be???


In Coronavirus Fight, Robots Report For Disinfection Duty
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/

Large-scale coronavirus testing continues to lag and a vaccine could be at least one year away. But in the battle against world pandemic a rapidly expanding brigade of robots is answering an urgent call of duty: surface disinfection.

They're rolling in by the hundreds and not just into hospitals and nursing homes but across a wide spectrum of public spaces, including government buildings, offices, hotels, airports and universities. Administrators of all stripes, desperate to keep people safe, are looking to a global robotics industry that has been quick to respond.

Denmark's UVD Robots, a leader in fully autonomous ultraviolet-light-disinfection robots, shipped hundreds of them to China in February and hundreds more throughout Europe in March. A much smaller number have arrived in the U.S. but several hundred more are on the way, said UVD Robots' CEO Per Juul Nielsen, speaking by telephone April 15.

"Hospitals around the world are waking up to autonomous disinfection," Nielsen said. "We can't build these robots fast enough.

"Healthcare-sector suppliers like UVD, Xenex and others still are a long way from being able to meet exploding global demand for automated disinfection solutions but it's not just specialized service robots riding into battle.

Human-friendly industrial robots, also known as collaborative robots, are being shifted away from tasks, such as machine tending and warehouse rack-stacking, and redeployed in the war on coronavirus.

The market for service robots in general has been growing. Some 271,000 of these types of robots were sold globally last year, according to data from the International Federation of Robotics. That's an increase of 61% over 2018.

Entering this year, UVD's view was that more healthcare institutions were going to want their robots owing to something else starting to spread — greater awareness about the dangers of healthcare associated infections.


Put another way, when a three-figure order from China came in February, Nielsen explained, it meant the company had nearly sold more robots that single day than it had during its full first year of commercial viability.

In the Middle East, where decision making is more centralized relative to Europe and the U.S., "some countries’ leaders have just said, ‘we need 100 of these robots,’" said Claus Risager, co-founder and CEO of Blue Ocean Robotics, speaking to The Robot Report.

Then came a targeted marketing campaign, moving from one regional healthcare sector to the next, in Scandinavian countries and eventually throughout Europe. Robot sales were steadily rising in 2019. At the end of last year, UVD projected an ambitious 2020 growth rate target: 400%.

"We already hit five times that," Nielsen said.


“We’re now seeing how mobile robots can be deployed to safeguard people, which, hopefully is changing negative perceptions some people have about robots,” said Jeff Burnstein, A3’s President. “What these applications for disinfecting, protecting hospital personnel, and related tasks illustrate is that robotics is an important technology to assist people, not replace them.”

Extra Extra Read All About it:

PCTL is cash flow positive and there is no DOUBT ABOUT IT!!!

The demand for Infection Controls Systems is not being met worldwide.

Profits for all who can provide systems!!!

PCTL PCTL PCTL

By the Numbers

271,000 Infection Controls Systems sold yearly!!!

Bids are being requested in the thousands!!!

Growth Rates Through The ROOF 400%...600%...2000%!!!

In Coronavirus Fight, Robots Report For Disinfection Duty

https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/

Why is PCTL stock set to make a major move?

First of all we need to understand the current trading area is based on the market makers just doing their job of creating a market.

PCTL have record breaking sales and revenues for Q1 and expected to have double digit growth in Q2 and beyond. That alone should be favorable to the stock price movement. Once one add on recent Annihilyzer sales and the movement increases.

What could launch stock price movement on a crazy run is knowledge.

The PCTL story is unknown to the trading public and the general public and for good reasons. It is a “stink pinky”. A lot of people won’t touch an OTC stock. It just went through some serious toxic financing. We had some very good local news stories about a small company from Little River, SC., however we need national news on the impact of HOCI during the Pandemic.

What major companies make and sell HOCI?


BASF SE. (Germany) OTCMKTS $48.80

Arkema S.A. (France) OTCMKTS $82.05

Lonza. (Swiss) OTCMKTS $480.00

Olin Corporation. NYSE $11.32

Nouryon (Private)

Occidental Petroleum Corporation. NYSE $14.67

Kuehne Company (Private)

AGC Chemicals (Private)

Surpass Chemical Company, Inc. Private

Westlake Chemical Corporation NYSE $42.02

When the story gets out about the impact of and the demand for Hypochlorous Acid during the pandemic and if Paradigm Convergence Technologies Corporation catches some press in the process then the possibility of an epic run may occur.

Why the epic run?

When people start to research HOCI and find out who the major players are they may want a piece of the action. Now some of the players listed are private so no action there. Many of the other ones although they make HOCI it is not necessary for disinfection in hospitals or similar businesses. Some will deliver 2500 gallons from a tank truck. Some are big into providing services to farms, diary, pool supplies distributors and water treatment plants.

If by happenstance some of these interested parties stubble across PCTL and take a close look they may take a dip and join the party.

PCTL went from the ashes of toxic financing to a company on a cash flow basis to cover the burn-rate in a six month period.

Due to increased attention as a result of the ongoing coronavirus pandemic, PCTL has been on an accelerated pace towards profitability and is preparing for double-digit growth into Q2 and beyond.

“Growth has been tremendous,” says CFO Marion Sofield, adding that the company is expecting to report record sales and revenues in Q1 2020.

“We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.

THe fact that HOCI is selling like hotcakes and demand has been outstripping supply should be national news.